(Q43236048)

16 November 2017

HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort (English)

1 reference

major depressive disorder

16 November 2017

1 reference

Norio Ozaki

12

0 references

Reiji Yoshimura

series ordinal

2

object named as

Reiji Yoshimura

1 reference

16 November 2017

11

Jun Nakamura

1 reference

16 November 2017

13

Nakao Iwata

1 reference

16 November 2017

1

Taro Kishi

1 reference

16 November 2017

3

Tsuyoshi Kitajima

1 reference

16 November 2017

4

Tomo Okochi

1 reference

16 November 2017

10

Hiroshi Naitoh

1 reference

16 November 2017

6

Tomoko Tsunoka

1 reference

16 November 2017

5

Takenori Okumura

1 reference

16 November 2017

Yoshio Yamanouchi

7

1 reference

PubMed ID

19937159

16 November 2017

Yoko Kinoshita

series ordinal

8

1 reference

PubMed ID

19937159

16 November 2017

Kunihiro Kawashima

series ordinal

9

1 reference

16 November 2017

24 November 2009

1 reference

16 November 2017

NeuroMolecular Medicine

1 reference

16 November 2017

12

1 reference

16 November 2017

3

1 reference

16 November 2017

237-242

1 reference

https://scigraph.springernature.com/pub.10.1007/s12017-009-8105-y

16 November 2017

0 references

cites work

A Structured Interview Guide for the Hamilton Depression Rating Scale

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12017-009-8105-Y

A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

21 January 2018

1 reference

12 December 2020

Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population

1 reference

12 December 2020

Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.

1 reference

12 December 2020

HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies

1 reference

12 December 2020

Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits

1 reference

12 December 2020

Pedigree disequilibrium tests for multilocus haplotypes.

1 reference

12 December 2020

Selective serotonin reuptake inhibitors: THREAD trial may show way forward

1 reference

12 December 2020

From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes

1 reference

12 December 2020

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

1 reference

12 December 2020

Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population

1 reference

12 December 2020

Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder

1 reference

12 December 2020

Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population.

1 reference

12 December 2020

CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients

1 reference

12 December 2020

Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy

1 reference

12 December 2020

5-HT2A SNPs and the Temperament and Character Inventory

1 reference

12 December 2020

The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions

1 reference

12 December 2020

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

1 reference

12 December 2020

The pharmacogenomics of selective serotonin reuptake inhibitors.

1 reference

12 December 2020

Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population

1 reference

12 December 2020

Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects

1 reference

12 December 2020

Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.

1 reference

12 December 2020

Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response

1 reference

12 December 2020

Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients

1 reference

12 December 2020

Molecular genetics of bipolar disorder and depression.

1 reference

12 December 2020

Strategies to Reduce Misdiagnosis of Bipolar Depression

1 reference

12 December 2020

Diagnosis of unipolar depression following initial identification of bipolar disorder: a common and costly misdiagnosis.

1 reference

12 December 2020

Polymorphisms in the regulatory region of the human serotonin 5-HT2A receptor gene (HTR2A) influence gene expression

1 reference

12 December 2020

10.1007/S12017-009-8105-Y

Identifiers

DOI

1 reference

16 November 2017

1 reference

PubMed ID

19937159